Uses of Lilonton

Lilonton drug has the main active ingredient Piracetam, which is considered a psychoactive substance. The drug has the ability to improve the metabolism of nerve cells, improve learning and memory. In normal people and people with impaired function, Piracetam acts directly on the brain to increase the activity of the brainstem region, the area of ​​the brain involved in the mechanism of cognition, learning, memory and consciousness.

Lilonton drug is indicated in the treatment of the following cases:
Treatment of diseases caused by brain damage such as mental disorders, hemiplegia. Treatment of symptoms of dizziness, headache caused by cerebral ischemia. Acute ischemic stroke, cerebrovascular accident. Behavioral disorders in children, learning difficulties, poor concentration. Cognitive decline in the elderly. Use support after trauma or surgery. Chronic alcoholism. Sickle cell anemia. Muscle tremors. Lilonton is contraindicated in the following patients:
Patients with severe renal impairment (creatinine clearance less than 20 ml/min). The patient has Huntington's disease. Patients with liver failure

The usual dose of Lilonton is 30-160 mg/kg/day, divided equally 2-4 times/day. Long-term treatment of psychosomatic syndromes in the elderly: Dosage 1.2 - 2.4 g/day, can be increased to 4.8 g/day in the first weeks. Treatment of alcoholism: The recommended dose is 12g/day for the first period of alcohol withdrawal, maintenance treatment at a dose of 2.4g/day. Supportive treatment in case of cognitive impairment after trauma or surgery: Initial dose is 9-12g/day, maintenance dose is 2.4g/day, taken for at least 3 weeks. Sickle cell anemia: The recommended dose is 160 mg/kg/day, divided equally into 4 times. Treatment of myoclonic tremor: The recommended dose is 7.2 g/day, divided into 2 - 3 times, depending on the response may be increased by 4.8 g/day to a maximum dose of 20 g/day. Patients with renal impairment:
CrCl above 80 mL/min: No dosage adjustment is required. CrCl 50 to 80 mL/min: Initial and maximum dose reduced to 2/3 of normal dose, given in 2 to 3 divided doses. CrCl 30 to 50 mL/min: Initial and maximum dose reduced to 1/3 of normal dose in 2 divided doses. CrCl 20 to 30 mL/min: Reduce to 1/6 of normal dose, once daily. CrCl less than 20 mL/min: Lilonton is contraindicated.

Patients using Lilonton c may experience side effects including:
Common: Fatigue, nausea, vomiting, diarrhea, abdominal pain, bloating, restlessness, agitation, headache, loss of appetite. sleep, slumber. Uncommon: Dizziness, tremor, sexual arousal

Because Piracetam is eliminated by the kidneys, caution should be exercised when administering the drug to patients with renal impairment. Renal function should be monitored in patients with pre-existing renal impairment and in the elderly. Pregnancy: Piracetam can cross the placenta. Therefore, Lilonton should not be used during pregnancy. Lactation: Piracetam should not be used by women who are breast-feeding.

Concomitant use of Lilonton with some other drugs may cause interactions, change the effectiveness and/or increase the side effects of the drug. Patients should inform their doctor of all medications and supplements they are taking for advice. Here are some drug interactions to watch out for when using Lilonton :
There have been reports of interactions between Piracetam and thyroid serum when taken concurrently, leading to confusion, irritability and sleep disturbances. Warfarin: In one patient, prothrombin time stabilized on warfarin was increased again with piracetam. The article has provided an overview of the drug Lilonton . The information above is for reference only and cannot replace the guidance of a physician. Patients should consult their doctor or pharmacist before taking the drug for maximum effectiveness.